Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Aiba

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Chemotherapy|September 6, 2007
Successful preoperative chemotherapy with S-1 plus low-dose cisplatin for advanced gastric cancer with synchronous liver metastases: report of 2 casesNaoto Takahashi, Hiroshi Nimura, Hiroaki Aoki, et al.
Oncology Letters|September 21, 2017
Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case reportYasuhiro Arakawa, Miho Tamura, Keisuke Aiba, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 14, 2010
Combined treatment with dendritic cells and 5-fluorouracil elicits augmented NK cell-mediated antitumor activity through the tumor necrosis factor-alpha pathwayEijiro Nagasaki, Akitaka Takahara, Shigeo Koido, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 9, 2015
Early measurement of urinary N-acetyl-β-glucosaminidase helps predict severe hyponatremia associated with cisplatin-containing chemotherapyYasuhiro Arakawa, Miho Tamura, Toshikazu Sakuyama, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2004
Phase I and pharmacokinetic study of KW-2170, a novel pyrazoloacridone compound, in patients with malignant tumorsToshiaki Saeki, Kenji Eguchi, Shigemitu Takashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 21, 2006
[Current status and problems in the chemotherapy of our outpatient clinic in the department of clinical oncology]Toshikazu Sakuyama, Keisuke Aiba, Daisuke Inoue, et al.
Japanese Journal of Clinical Oncology|March 26, 2014
Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patientsKazuhito Suzuki, Yasuhito Terui, Noriko Nishimura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2015
[Human herpesvirus 8-negative primary effusion lymphoma-like lymphoma with t(8;14)(q24;q32)]Yoji Ogasawara, Tomohito Machishima, Takaki Shimada, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2014
Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancerTadashi Uwagawa, Taro Sakamoto, Kyohei Abe, et al.
Cancer|February 22, 2002
Irinotecan hydrochloride for the treatment of recurrent and refractory non-Hodgkin lymphoma: a single institution experienceKatsuki Sugiyama, Ken Omachi, Keiichi Fujiwara, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Chemotherapy|September 6, 2007
Successful preoperative chemotherapy with S-1 plus low-dose cisplatin for advanced gastric cancer with synchronous liver metastases: report of 2 casesNaoto Takahashi, Hiroshi Nimura, Hiroaki Aoki, et al.
Oncology Letters|September 21, 2017
Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case reportYasuhiro Arakawa, Miho Tamura, Keisuke Aiba, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 14, 2010
Combined treatment with dendritic cells and 5-fluorouracil elicits augmented NK cell-mediated antitumor activity through the tumor necrosis factor-alpha pathwayEijiro Nagasaki, Akitaka Takahara, Shigeo Koido, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 9, 2015
Early measurement of urinary N-acetyl-β-glucosaminidase helps predict severe hyponatremia associated with cisplatin-containing chemotherapyYasuhiro Arakawa, Miho Tamura, Toshikazu Sakuyama, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2004
Phase I and pharmacokinetic study of KW-2170, a novel pyrazoloacridone compound, in patients with malignant tumorsToshiaki Saeki, Kenji Eguchi, Shigemitu Takashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 21, 2006
[Current status and problems in the chemotherapy of our outpatient clinic in the department of clinical oncology]Toshikazu Sakuyama, Keisuke Aiba, Daisuke Inoue, et al.
Japanese Journal of Clinical Oncology|March 26, 2014
Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patientsKazuhito Suzuki, Yasuhito Terui, Noriko Nishimura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2015
[Human herpesvirus 8-negative primary effusion lymphoma-like lymphoma with t(8;14)(q24;q32)]Yoji Ogasawara, Tomohito Machishima, Takaki Shimada, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2014
Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancerTadashi Uwagawa, Taro Sakamoto, Kyohei Abe, et al.
Cancer|February 22, 2002
Irinotecan hydrochloride for the treatment of recurrent and refractory non-Hodgkin lymphoma: a single institution experienceKatsuki Sugiyama, Ken Omachi, Keiichi Fujiwara, et al.
Pageof 8